← All news
Markets

Protagonist Therapeutics: "Strong Buy" ICOTYDE FDA Approval And PN-881 Advancement

1 source ·1 article ·Aug 12, 11:35 UTC PN Smart Energy Protagonist Therapeutics

Covered by 1 outlet

All coverage · 1 article